Practical performance of the 2015 American Thyroid Association guidelines for predicting tumor recurrence in patients with papillary thyroid cancer in South Korea

SG Lee, WK Lee, HS Lee, J Moon, CR Lee, SW Kang… - Thyroid, 2017 - liebertpub.com
… Differentiated thyroid cancer is the most common … thyroid cancer has invited debate about
the appropriate management strategy for such patients, particularly those with papillary thyroid

Simplifying the TNM system for clinical use in differentiated thyroid cancer

AA Onitilo, JM Engel, CI Lundgren, P Hall… - Journal of clinical …, 2009 - ascopubs.org
… For example, if one adds to the TNM stages for thyroid cancer age information (two groups:
… Because the primary utility of the TNM staging system is its simplicity as a “look-up” table in …

Immune landscape of papillary thyroid cancer and immunotherapeutic implications

KJ Na, H Choi - Endocrine-related cancer, 2018 - erc.bioscientifica.com
… From the comprehensive analysis, we focused on the clinical utility of immune landscape
on prognostic stratification and potential implication as a biomarker reflecting immune …

Construction of a tumor immune microenvironment-related prognostic model in BRAF-mutated papillary thyroid cancer

Y Xia, X Jiang, Y Huang, Q Liu, Y Huang… - Frontiers in …, 2022 - frontiersin.org
… TIME-related prognostic model to … utility of the nomogram versus the risk score model in
the BRAF-mutated PTC cohort. Moreover, we determined the associations between prognostic

Prognostic value of FDG-PET/CT metabolic parameters in metastatic radioiodine-refractory differentiated thyroid cancer

PM Manohar, LJ Beesley, EL Bellile… - Clinical nuclear …, 2018 - journals.lww.com
… Our study demonstrates the utility metabolic imaging with FDG PET/CT for prognosis in …
variability in thyroid cancer patients, distinguishing 2 phenotypes in metastatic thyroid cancer—…

EZH2 overexpression as a useful prognostic marker for aggressive behaviour in thyroid cancer

K Masudo, N Suganuma, H Nakayama, T Oshima… - In vivo, 2018 - iv.iiarjournals.org
… We analyzed EZH2 protein expression levels in different histological subtypes of thyroid
cancer to examine its utility as a prognostic factor. Materials and Methods: We examined EZH2 …

Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer

F Pacini, MG Castagna - Best Practice & Research Clinical Endocrinology & …, 2008 - Elsevier
Traditionally, withdrawal of thyroid hormone to increase serum levels of thyroid-stimulating
hormone (TSH) has been used in patients with differentiated thyroid carcinoma (DTC) to …

Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients

L Yip, MN Nikiforova, JY Yoo, KL McCoy… - Annals of …, 2015 - journals.lww.com
… What I am still not clear about is the clinical utility of routine molecular testing in all
patients with papillary thyroid cancer. What I learn from your data is that the overall disease-specific …

Diagnostic value of 16 cellular tumor markers for metastatic thyroid cancer: an immunohistochemical study

H Liang, Y Zhong, Z Luo, Y Huang, H Lin… - Anticancer …, 2011 - ar.iiarjournals.org
Background: The prognosis for thyroid cancer differs between metastatic and non-… thyroid
cancer diagnosis and to establish a marker panel for the early detection of metastatic thyroid

Surgical options for thyroid cancer and post-surgical management

A Doubleday, RS Sippel - Expert review of endocrinology & …, 2018 - Taylor & Francis
thyroid cancer (DTC), which includes papillary and follicular, is the most common type of
thyroid cancer and … In this review, we will highlight some of the updates in the American Thyroid